A breakthrough for lung cancer treatment?

Episode 23

Free Associations Podcast | June 5th, 2018


Epidemiology, Research Methods

Matt, Chris, and Don discuss a new treatment for lung cancer (immunotherapy), the gang discusses a controversy that occurred when a large clinical trial decided to change its endpoint, and Chris dives into the world of linguistics (again).

Journal club article:

Pembrolizumab lung cancer trial